Sep 14, 2021 / 01:00PM GMT
Sarah Rouan;Chairman of the Board -
Good morning, fellow stockholders. I am Kathy Rouan, Chair of the Board of Directors of Navidea Biopharmaceuticals. I will be the chairperson of this meeting. To support the health and well-being of our stockholders and their families, due to the public health impact of the coronavirus pandemic, we are holding this meeting virtually via webcast. The agenda for this meeting is set forth on your screen and in the Notice of the Meeting.
The 2021 Annual Meeting of Stockholders is now called to order. First, let me welcome you to Navidea's 2021 Annual Meeting. I am pleased that you could join us today. I would now like to introduce to you the other directors of the company who are with us either in person or by phone today: Mr. Amit Bhalla, Dr. Claudine Bruck, Mr. Alex Cappello, Mr. Jed Latkin, Mr. Kim Scott and Mr. Max Witter. Mike Brooder and Katelyn Castonguay of Marcum LLP, the company's independent registered public accounting firm; and Alan Gilbert of Maslon LLP, Corporate Counsel to the company, are also present by phone.
The secretary of
Navidea Biopharmaceuticals Inc Annual Shareholders Meeting Transcript
Feb 14, 2024
Already have an account? Log in
Get the full story
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
30-Day 100% money back guarantee
You are not charged until the trial ends. Subscription fee may be tax deductible.
Excellent 
4.6 out of 5 
Trustpilot
Trustpilot
Survey
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
Follow Us
Disclaimers